Erez Aminov
CIK: 0001986112
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
Award(A)DirectIncentive Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
Disposition(D)DirectNon-Qualified Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
Award(A)DirectNon-Qualified Stock Options (right to buy)
2M shares- - May 21, 2026TELO
Telomir Pharmaceuticals, Inc.
Disposition(D)DirectIncentive Stock Options (right to buy)
2M shares- - Apr 22, 2026TELO
Telomir Pharmaceuticals, Inc.
Other(J)Direct7.3M shares at avg. $1.37$10.0M - Mar 30, 2026MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
83.5K shares- - Dec 17, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectStock Options (right to buy)
3.2M shares- - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Sale(S)Direct613.6K shares at avg. $2.11$1.3M - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Exercise(M)Direct234.6K shares at avg. $1.16$272K - Oct 16, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Exercise(M)Direct379K shares at avg. $0.84$318K - Oct 1, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)Direct2.7M shares- - Sep 18, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectStock Options (right to buy)
150K shares- - Sep 18, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectStock Options (right to buy)
150K shares- - Aug 29, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)Direct62.5K shares at avg. $1.37$86K - May 28, 2025TELO
Telomir Pharmaceuticals, Inc.
Award(A)DirectNon-Qualified Options
2M shares- - May 28, 2025TELO
Telomir Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units (RSUs)
400K shares- - Mar 26, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)Direct62.5K shares at avg. $1.45$91K - Mar 26, 2025MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)Direct62.5K shares at avg. $1.45$91K - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectStock Options (right to buy)
2M shares- - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectRestricted Stock Units
500K shares- - Nov 20, 2024MIRA
MIRA PHARMACEUTICALS, INC.
Sale(S)Direct44.6K shares at avg. $1.27$57K - Nov 19, 2024MIRA
MIRA PHARMACEUTICALS, INC.
Sale(S)Direct55.4K shares at avg. $1.39$77K - Aug 19, 2024TELO
Telomir Pharmaceuticals, Inc.
Sale(S)Direct200 shares at avg. $6.20$1K - Aug 19, 2024TELO
Telomir Pharmaceuticals, Inc.
Sale(S)Direct200 shares at avg. $6.01$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  TELO Telomir Pharmaceuticals, Inc. | Award(A) Incentive Stock Options (right to buy) | 1,960,170 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Disposition(D) Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Award(A) Non-Qualified Stock Options (right to buy) | 2,000,000 | - | - | Direct |
| May 21, 2026 | TELO Telomir Pharmaceuticals, Inc. | Disposition(D) Incentive Stock Options (right to buy) | 1,960,170 | - | - | Direct |
| Apr 22, 2026 | TELO Telomir Pharmaceuticals, Inc. | Other(J) | 7,319,710 | $1.37 | $10,028,003 | Direct |
| Mar 30, 2026 |  MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 83,500 | - | - | Direct |
| Dec 17, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Stock Options (right to buy) | 3,155,170 | - | - | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Sale(S) | 613,595 | $2.11 | $1,294,685 | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Exercise(M) | 234,595 | $1.16 | $272,130 | Direct |
| Oct 16, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Exercise(M) | 379,000 | $0.84 | $318,360 | Direct |
| Oct 1, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) | 2,685,456 | - | - | Direct |
| Sep 18, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Stock Options (right to buy) | 150,000 | - | - | Direct |
| Sep 18, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Stock Options (right to buy) | 150,000 | - | - | Direct |
| Aug 29, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) | 62,500 | $1.37 | $85,625 | Direct |
| May 28, 2025 | TELO Telomir Pharmaceuticals, Inc. | Award(A) Non-Qualified Options | 2,000,000 | - | - | Direct |
| May 28, 2025 | TELO Telomir Pharmaceuticals, Inc. | Award(A) Restricted Stock Units (RSUs) | 400,000 | - | - | Direct |
| Mar 26, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) | 62,500 | $1.45 | $90,625 | Direct |
| Mar 26, 2025 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) | 62,500 | $1.45 | $90,625 | Direct |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Stock Options (right to buy) | 2,000,000 | - | - | Direct |
| Dec 9, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Restricted Stock Units | 500,000 | - | - | Direct |
| Nov 20, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | Sale(S) | 44,590 | $1.27 | $56,629 | Direct |
| Nov 19, 2024 | MIRA MIRA PHARMACEUTICALS, INC. | Sale(S) | 55,410 | $1.39 | $77,020 | Direct |
| Aug 19, 2024 | TELO Telomir Pharmaceuticals, Inc. | Sale(S) | 200 | $6.20 | $1,240 | Direct |
| Aug 19, 2024 | TELO Telomir Pharmaceuticals, Inc. | Sale(S) | 200 | $6.01 | $1,202 | Direct |
1-24 of 24 transactions
About Aminov Erez
Aminov Erez (SEC CIK 0001986112) files insider reports with the SEC as CEO and Chairman of Telomir Pharmaceuticals, Inc. (TELO) and CEO and Chairman of MIRA PHARMACEUTICALS, INC. (MIRA).
Signal8 holds 11 ownership filings by Aminov Erez (9 Form 4, 2 Form 5), filed between Nov 27, 2024 and May 22, 2026. Those filings report 24 transactions, from Aug 19, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Aminov Erez's filings is in MIAMI, FL.
Recent filings by Aminov Erez
- May 21, 2026: Grant or award of TELO derivative securities (Form 4, code A).
- May 21, 2026: Disposition to issuer transaction of TELO derivative securities (Form 4, code D).
- May 21, 2026: Grant or award of TELO derivative securities (Form 4, code A).
- May 21, 2026: Disposition to issuer transaction of TELO derivative securities (Form 4, code D).
- Apr 22, 2026: Other transaction of TELO shares (Form 4, code J).
Other insiders filing for Telomir Pharmaceuticals, Inc. (TELO)
- Whalen Matthew Pratt, Director
- MacPherson Edward Clouston, Director
- Del Giudice Matthew Paul, Director
- Mushak Andriy, Chief Financial Officer
- MIRA PHARMACEUTICALS, INC., 10% Owner
- Weichselbaum Alan, Chief Financial Officer